Navigation Links
Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
Date:10/20/2010

co.

DISCLOSURE NOTICE: The information contained in this release is as of October 20, 2010. The Company assumes no obligation to update forward-looking statements contained in this release as a result of new information or future events or developments.

This release contains forward-looking information about an agreement by Pfizer to acquire a 40% stake in Teuto Laboratories (Teuto), commercial agreements to be entered into between Pfizer and Teuto, and the potential benefits of the proposed transaction. Such information involves substantial risks and uncertainties including, among other things, the satisfaction of conditions to closing the agreements; Pfizer's ability to successfully commercialize the products covered by the agreements; decisions by regulatory authorities regarding whether and when to approve any drug applications that may be filed for such products as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of such products; and competitive developments.

A further list and description of risks and uncertainties can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.


'/>"/>
SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 2, 2014  MJ Freeway®, the industry-leading cannabis business ... detailing upcoming legalization efforts in Oregon ... Nevada .  The success of the measures being ... on the national level. On October 7th, ... the Marijuana Policy Project, an organization dedicated to making ...
(Date:10/2/2014)... , Oct. 2, 2014  Isis Pharmaceuticals, Inc. ... webcast:What: , Webcast and conference call to provide ... clinical studies of ISIS-SMN Rx in infants ... will be presented on the morning (CEST) of ... Muscle Society in Berlin, GermanyWhen:Friday, October 10 at ...
(Date:10/1/2014)... Calif. , Oct. 1, 2014  Abaxis, Inc. ... manufacturing point-of-care instruments and consumables for the medical, research, ... to the veterinary and research markets in ... entered into a definitive distribution agreement with Patterson Veterinary ... and promote the full line of Abaxis veterinary products ...
Breaking Medicine Technology:MJ Freeway to Host Educational Webinars Regarding Crucial Marijuana Legalization Efforts in Alaska, Nevada and Oregon 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 3Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 4
(Date:10/2/2014)... 02, 2014 Originally considered alternative ... is becoming increasingly popular with consumers. This has ... Poultry Farming industry in Australia. According to ... organic meat has surged over the past five ... the farming level.” Over the five years through ...
(Date:10/2/2014)... (HealthDay News) -- Scientists have pinpointed a molecule that ... colds. The researchers say this finding could offer ... treat these attacks. Most asthma attacks (80 percent ... the airways, according to the British researchers. Most of ... the common cold. The researchers found that a ...
(Date:10/2/2014)... Dennis Thompson HealthDay ... A newborn,s risk of developing celiac disease isn,t reduced by ... in wheat called gluten to an infant,s diet help prevent ... pair of new studies in the Oct. 2 New ... to rest hopes that a child could avoid celiac disease ...
(Date:10/2/2014)... University of Nottingham could lead to the development of ... resulting from the research, published in the journal ... sufferers of chronic pain conditions such as traumatic nerve ... , The work, led by Dr Lucy Donaldson in ... David Bates, Professor of Oncology in the University,s Cancer ...
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
Breaking Medicine News(10 mins):Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 4Health News:New Clues to How Colds Can Spur Asthma Attacks 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 3Health News:Medical discovery first step on path to new painkillers 2Health News:Study finds acupuncture does not improve chronic knee pain 2
... 29 LodgeNet Interactive Corporation (Nasdaq: LNET ... offering of 50,000 shares of 10% Series B Cumulative ... liquidation preference of $1,000 per share. In addition, the ... to purchase an additional 7,500 shares of preferred stock ...
... HealthCare System has organized a new business unit ... North and South Carolina. , , The newly ... (SHVI) represents a combination of Sanger Clinic, Charlotte Cardiology Associates ... serving as a regional referral center for highly specialized care. ...
... Clovis Students Win Thousands of Dollars in Milk Contest , ... month after month with Premenstrual Syndrome, a.k.a. man,s worst nightmare. ... whom do not yet know that milk could be the ... effort to educate women on the PMS-fighting benefits of the ...
... ... to share their perspectives on eye care and safety. , ... Minneapolis, MN (PRWEB) June 29, 2009 -- Stop squinting…proper eye ... July,s fireworks displays in all their brilliance and clarity., , , The Healthcare Scoop , ...
... , JACKSONVILLE, Fla., June 29 On June ... the European Association for the Study of Diabetes investigated ... sanofi-aventis) and the development of certain malignancies. The authors ... their limited data and analyses, which precluded them from ...
... most parents of high school and college-age students and they,ll tell ... life,s tough questions. Truth is, at that age they are forming ... their lives. A new initiative, Reach Teach Learn , is ... that honest, educated decisions are made. , , Alpharma Inc., ...
Cached Medicine News:Health News:LodgeNet Interactive Announces Completion of Offering of $57.5 Million of Convertible Preferred Stock 2Health News:LodgeNet Interactive Announces Completion of Offering of $57.5 Million of Convertible Preferred Stock 3Health News:LodgeNet Interactive Announces Completion of Offering of $57.5 Million of Convertible Preferred Stock 4Health News:Sanger Clinic Lends Its Name to New Heart Care Institute Serving NC and SC 2Health News:No More Drama With TOMA LECHE 2Health News:No More Drama With TOMA LECHE 3Health News:No More Drama With TOMA LECHE 4Health News:The Healthcare Scoop Community Says 'Eye Care' 2Health News:The Healthcare Scoop Community Says 'Eye Care' 3Health News:AACE Response to Insulin Glargine Cancer Risk Articles in Diabetologia 2Health News:Alpharma's Reach Teach Learn Initiative Targets Youth and Consumer Awareness 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: